---
kind: "section"
citation: "40 C.F.R. § 721.11289"
title: "40"
number: "721.11289"
heading: "1-Butanaminium,N,N,N-tributyl-,2(or 5)- [[benzoyldihydrodioxo [(sulfophenyl) amino]heteropolycycle]oxy]-5(or 2)-(1,1-dimethylpropyl)benzenesulfonate (2:1) (generic)."
url: "https://uscodex.org/cfr/40/721.11289"
---

# §721.11289. 1-Butanaminium,N,N,N-tributyl-,2(or 5)- [[benzoyldihydrodioxo [(sulfophenyl) amino]heteropolycycle]oxy]-5(or 2)-(1,1-dimethylpropyl)benzenesulfonate (2:1) (generic).

- (a) **Chemical substance and significant new uses subject to reporting.**
  - (1) The chemical substance identified generically as 1-butanaminium,N,N,N-tributyl-,2(or 5)- [[benzoyldihydrodioxo [(sulfophenyl) amino]heteropolycycle]oxy]-5(or 2)-(1,1-dimethylpropyl)benzenesulfonate (2:1) (PMN P-18-136) is subject to reporting under this section for the significant new uses described in [paragraph (a)(2)](#a-2) of this section.
  - (2) **The significant new uses are—**
    - (i) **Industrial, commercial, and consumer activities.** It is a significant new use to manufacture, process, or use the substance in any manner that results in inhalation exposure.
    - (ii) **Release to water.** Requirements as specified in § [721.90(a)(4)](/cfr/40/721.90.md?p=a-4), [(b)(4)](/cfr/40/721.90.md?p=b-4), and [(c)(4)](/cfr/40/721.90.md?p=c-4), where N=19.
- (b) **Specific requirements.** The provisions of [subpart A](/cfr/40/subpartA.md) of this part apply to this section except as modified by this [paragraph (b)](#b).
  - (1) **Recordkeeping.** Recordkeeping requirements as specified in [§ 721.125(a)](/cfr/40/721.125.md?p=a) though (c), (i), and (k) are applicable to manufacturers and processors of this substance.
  - (2) **Limitation or revocation of certain notification requirements.** The provisions of [§ 721.185](/cfr/40/721.185.md) apply to this section.

## Notes

### Amendments

[86 FR 24333, May 6, 2021]

### Authority

Authority: 15 U.S.C. 2604, 2607, and 2625(c).

### Source

Source: 49 FR 35018, Sept. 5, 1984, unless otherwise noted.

### Amendments

[86 FR 24333, May 6, 2021]
